Rationale and Design of RESILIENCE: A Prospective Randomized Clinical Trial Evaluating Remote Ischaemic Conditioning for the Prevention of Anthracycline Cardiotoxicity

The RESILIENCE trial will test RIC (a novel non-invasive intervention to prevent AC) in a cohort of high-risk patients. The trial will also test candidate markers for their capacity to predict AC and will validate a novel CMR sequence reducing acquisition time in a vulnerable population.

Authors

Institutions

Publication Details

Journal
European Journal of Heart Failure
Published
2024-08-30
DOI
https://doi.org/10.1002/ejhf.3395
Citations
11
Primary Topic
Cardiac Ischemia and Reperfusion
Type
article
Field-Weighted Citation Impact
4.67

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Rationale and Design of RESILIENCE: A Prospective Randomized Clinical Trial Evaluating Remote Ischaemic Conditioning for the Prevention of Anthracycline Cardiotoxicity

Teresa López‐Fernández, Malte Kelm, Francesco d’Amore, Alberto López García et al.
11 citations
European Journal of Heart Failure
Cardiac Ischemia and Reperfusion
4.67
article

Rationale and Design of RESILIENCE: A Prospective Randomized Clinical Trial Evaluating Remote Ischaemic Conditioning for the Prevention of Anthracycline Cardiotoxicity

Teresa López‐Fernández, Malte Kelm, Francesco d’Amore, Alberto López García, Sandra Gómez‐Talavera, Jouke Smink, Noemí Escalera, Borja Ibáñez, A Ferreira, María Gomes da Silva, Marie José Kersten, Xavier Rosselló, Natacha Bolaños, Javier Sánchez‐Gonzalez, Vincent Camus, Riccardo Asteggiano, Raúl Córdoba, Andrea Moreno‐Arciniegas, Pedro L. Sánchez, Antonio J. Quesada, Elsa Pacella
article en
11 citations

Abstract

The RESILIENCE trial will test RIC (a novel non-invasive intervention to prevent AC) in a cohort of high-risk patients. The trial will also test candidate markers for their capacity to predict AC and will validate a novel CMR sequence reducing acquisition time in a vulnerable population.

European Journal of Heart FailureVol. 26(10)
University of Insubria (IT), Philips (Finland) (FI), Inserm (FR), European Society of Radiology (AT), Aarhus University Hospital (DK), Spanish National Centre for Cardiovascular Research (ES), European Society of Cardiology (FR), Instituto Superior Autónomo de Estudos Politécnicos (PT), Düsseldorf University Hospital (DE), Centro de Investigación en Red en Enfermedades Cardiovasculares (ES), Complejo Hospitalario de Salamanca (ES), Hospital La Paz Institute for Health Research (ES), IPO Porto (PT), Philips (Spain) (ES), Philips (Netherlands) (NL), Hospital da Luz (PT), Hospital Universitario Fundación Jiménez Díaz (ES), Laboratoire National Henri Becquerel (FR), Iberia (Spain) (ES), Centre Virchow-Villermé (FR), Amsterdam University Medical Centers (NL), Hospital Universitario Son Espases (ES), Centre Henri Becquerel, Heinrich Heine University Düsseldorf (DE), University of Amsterdam (NL), Universidad Europea de Madrid (ES)
European Commission, Horizon 2020 Framework Programme
Openalex Percentile: Top 5%
Cardiac Ischemia and Reperfusion
4.67
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.